Home bristolmyers
 

Keywords :   


Tag: bristolmyers

Vetr Inc. Lowers Bristol-Myers Squibb Co (BMY) to Hold

2016-04-05 10:56:15| Biotech - Topix.net

They presently have a $67.61 target price on the biopharmaceutical company's stock. Vetr 's target price suggests a potential upside of 2.49% from the company's current price.

Tags: to hold lowers squibb

 

Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.

2016-03-30 03:53:43| drugdiscoveryonline Home Page

Bristol-Myers Squibb Company and Padlock Therapeutics, Inc. announced recently that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Padlock, a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases

Tags: acquire therapeutics squibb padlock

 
 

BTR Capital Management Has $520,000 Position in Bristol-Myers Squibb Co

2016-02-10 07:01:40| Biotech - Topix.net

BTR Capital Management raised its position in shares of Bristol-Myers Squibb Co by 8.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,565 shares of the biopharmaceutical company's stock after buying an additional 600 shares during the period.

Tags: management position capital squibb

 

Bristol-Myers posts 4Q loss, but beats views as sales rise

2016-01-28 15:49:17| Biotech - Topix.net

Bristol-Myers Squibb Co. swung from a tiny profit to a loss in the fourth quarter as it fought multiple headwinds, but it still beat Wall Street expectations.

Tags: sales posts views loss

 

Reasons to Expect Strong Bristol-Myers Earnings

2016-01-26 03:13:49| Biotech - Topix.net

Recent market volatility and global pressures have tempered investors' expectations for a strong earnings season, but not all companies will do poorly. Although Bristol-Myers Squibb shares -- down some 7% year to date -- is not off to a good start in 2016, the multinational drug giant belongs on any short list of companies poised to beat Wall Street's earnings estimates.

Tags: strong reasons expect earnings

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] next »